Extension Study to Evaluate the Long-term Efficacy and Safety of Everolimus in Liver Transplant Recipients

NCT01150097 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

284

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Transplant Recipient

Interventions

DRUG: Tacrolimus (reduced tacrolimus)
DRUG: Everolimus (reduced tacrolimus)
DRUG: Tacrolimus (tacrolimus elimination)
DRUG: Everolimus (tacrolimus elimination)
DRUG: Tacrolimus (tacrolimus control)
DRUG: Corticosteroids

Sponsor

Novartis Pharmaceuticals